Autor: "Sajadi MM" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Discordant Antigenic Properties of Soluble and Virion SARS-CoV-2 Spike Proteins.
Autorzy:: Kumar S; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.
Dasgupta S; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.
Sajadi MM; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.; Division of Clinical Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.; Department of Medicine, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.
Snyder GA; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.; Department of Medicine, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.
DeVico AL; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.; Department of Medicine, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.
Ray K; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 725 West Lombard Street, Baltimore, MD 21201, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 06; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*
HIV-1*
Humans ; Spike Glycoprotein, Coronavirus ; SARS-CoV-2 ; Pandemics ; Antibodies, Neutralizing ; HIV Antibodies/analysis ; Antibodies, Monoclonal ; Virion/metabolism ; Antibodies, Viral/chemistry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Maternal transfer of IgA and IgG SARS-CoV-2 specific antibodies transplacentally and via breast milk feeding.
Autorzy:: Sajadi MM; VA Maryland Healthcare Center, Baltimore, MD, United States of America.; Institute of Human Virology, Baltimore, MD, United States of America.
Shokatpour N; Institute of Human Virology, Baltimore, MD, United States of America.
Purcell M; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Tehrani ZR; Institute of Human Virology, Baltimore, MD, United States of America.
Lankford A; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Bathula A; University of Maryland Medical Center, Baltimore, MD, United States of America.
Campbell JD; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Hammershaimb EA; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Deatrick KB; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Bor C; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Parsell DM; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Dugan C; University of Maryland Medical Center, Baltimore, MD, United States of America.
Levine AR; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Ramelli SC; National Institutes of Health, Bethesda, MD, United States of America.
Chertow DS; National Institutes of Health, Bethesda, MD, United States of America.
Herr DL; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Saharia KK; Institute of Human Virology, Baltimore, MD, United States of America.; University of Maryland School of Medicine, Baltimore, MD, United States of America.
Lewis GK; Institute of Human Virology, Baltimore, MD, United States of America.
Grazioli A; University of Maryland School of Medicine, Baltimore, MD, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Apr 06; Vol. 18 (4), pp. e0284020. Date of Electronic Publication: 2023 Apr 06 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Milk, Human*
COVID-19*/prevention & control
Infant ; Female ; Humans ; Cross-Sectional Studies ; SARS-CoV-2 ; Breast Feeding ; Antibodies, Viral ; Immunoglobulin A ; Immunoglobulin G

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Determining the SARS-CoV-2 serological immunoassay test performance indices based on the test results frequency distribution.
Autorzy:: Habibzadeh F; Global Virus Network, Middle East Region, Shiraz, Iran.
Habibzadeh P; Research Center for Health Sciences, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Yadollahie M; Freelance Researcher, Shiraz, Iran.
Sajadi MM; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, USA.; Global Virus Network, Baltimore, USA.; Pokaż więcej
Źródło:: Biochemia medica [Biochem Med (Zagreb)] 2022 Jun 15; Vol. 32 (2), pp. 020705.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/diagnosis
COVID-19*/epidemiology
SARS-CoV-2*
Antibodies, Viral ; Humans ; Immunoassay/methods ; Immunoglobulin G ; Sensitivity and Specificity ; Seroepidemiologic Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Use of oral polio vaccine and the incidence of COVID-19 in the world.
Autorzy:: Habibzadeh F; Global Virus Network, Middle East Region, Shiraz, Iran.; Research and Development Headquarters, Petroleum Industry Health Organization, Shiraz, Iran.
Chumakov K; Office of Vaccines Research and Review, Food and Drug Administration, Global Virus Network Center of Excellence, Silver Spring, Maryland, United States of America.
Sajadi MM; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Global Virus Network, Baltimore, Maryland, United States of America.
Yadollahie M; Freelance Researcher, Shiraz, Iran.
Stafford K; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Global Virus Network, Baltimore, Maryland, United States of America.
Simi A; Research and Development Headquarters, Petroleum Industry Health Organization, Shiraz, Iran.
Kottilil S; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Global Virus Network, Baltimore, Maryland, United States of America.
Hafizi-Rastani I; Research and Development Headquarters, Petroleum Industry Health Organization, Shiraz, Iran.
Gallo RC; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Global Virus Network, Baltimore, Maryland, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Mar 17; Vol. 17 (3), pp. e0265562. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19/*epidemiology
Global Health/*statistics & numerical data
Poliovirus Vaccine, Oral/*therapeutic use
COVID-19/prevention & control ; Humans ; Incidence ; Poliovirus Vaccine, Inactivated/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Combined cART including Tenofovir Disoproxil, Emtricitabine, and Dolutegravir has potent therapeutic effects in HIV-1 infected humanized mice.
Autorzy:: Weichseldorfer M; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Affram Y; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.; Department of Microbial Pathogenesis and Immunology, University of Texas A and M Health Science Center, Bryan, TX, 77843, USA.
Heredia A; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.; Department of Medicine, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Rikhtegaran-Tehrani Z; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Sajadi MM; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.; Department of Medicine, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Williams SP; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Tagaya Y; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.; Department of Medicine, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Benedetti F; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.; Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Ramadhani HO; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Denaro F; Morgan State University, College of Bio Sciences, Baltimore, MD, 21011, USA.
Munawwar A; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Bryant J; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Zella D; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.; Department of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Reitz M; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.
Romerio F; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.; Department of Medicine, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA.; Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, 21201, USA.
Latinovic OS; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA. .; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, MD, 21201, USA. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2021 Oct 30; Vol. 19 (1), pp. 453. Date of Electronic Publication: 2021 Oct 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV-1*
Animals ; Emtricitabine/pharmacology ; Emtricitabine/therapeutic use ; Heterocyclic Compounds, 3-Ring ; Mice ; Oxazines ; Piperazines ; Pyridones ; Tenofovir/pharmacology ; Tenofovir/therapeutic use ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.
Autorzy:: Hastie KM; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Li H; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Bedinger D; Carterra, 825 N. 300 W. Ste C309, Salt Lake City, UT 84103, USA.
Schendel SL; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Dennison SM; Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.
Li K; Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.
Rayaprolu V; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Yu X; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Mann C; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Zandonatti M; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Diaz Avalos R; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Zyla D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Buck T; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Hui S; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Shaffer K; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Hariharan C; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Yin J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Olmedillas E; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Enriquez A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Parekh D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Abraha M; Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.
Feeney E; Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.
Horn GQ; Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.
Aldon Y; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, Netherlands.
Ali H; Quadrucept Bio, Ltd., Cambridge CB23 6DW, UK.
Aracic S; Myrio Therapeutics Pty, Ltd., 1 Dalmore Drive, Scoresby, VIC 3179, Australia.
Cobb RR; National Resilience, Inc., 13200 NW Nano Ct., Alachua, FL 32615, USA.
Federman RS; Generate Biomedicines, Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA.
Fernandez JM; Activemotif, Inc., 1914 Palomar Oaks Way, Suite 150, Carlsbad, CA 92008, USA.
Glanville J; Centivax, Inc., 201 Gateway Blvd., Floor 1, South San Francisco, CA 94080, USA.
Green R; Generate Biomedicines, Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA.
Grigoryan G; Generate Biomedicines, Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA.
Lujan Hernandez AG; Twist Bioscience, 681 Gateway Blvd., South San Francisco, CA 94080, USA.
Ho DD; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, 701 West 168th St., HHSC 1102, New York, NY 10032, USA.
Huang KA; Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital and Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan, Taiwan.
Ingraham J; Generate Biomedicines, Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA.
Jiang W; Shanghai Henlius Biotech, Inc., 9/F, Innov Tower, Zone A, no. 1801 Hongmei Road, Xuhui District, Shanghai, China.
Kellam P; Kymab, Ltd., The Bennet Building, Babraham Research Campus, Cambridge CB22 3AT, UK.; Department of Infectious Disease, Imperial College, London SW7 2AZ, UK.
Kim C; Celltrion, Inc., Department of Research and Development, 23 Academy-ro Yeonsu-gu Incheon, Republic of Korea.
Kim M; Celltrion, Inc., Department of Research and Development, 23 Academy-ro Yeonsu-gu Incheon, Republic of Korea.
Kim HM; Celltrion, Inc., Department of Research and Development, 23 Academy-ro Yeonsu-gu Incheon, Republic of Korea.
Kong C; Sanyou Biopharmaceuticals Co., Ltd., no. 188 Xinjunhuan Road, Building 6B-C, 3rd Floor, Minhang District, Shanghai 201114, China.
Krebs SJ; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
Lan F; Activemotif, Inc., 1914 Palomar Oaks Way, Suite 150, Carlsbad, CA 92008, USA.; Shanghai Key Laboratory of Medical Epigenetics, International Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Lang G; Sanyou Biopharmaceuticals Co., Ltd., no. 188 Xinjunhuan Road, Building 6B-C, 3rd Floor, Minhang District, Shanghai 201114, China.
Lee S; Celltrion, Inc., Department of Research and Development, 23 Academy-ro Yeonsu-gu Incheon, Republic of Korea.
Leung CL; Generate Biomedicines, Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA.
Liu J; Shanghai Henlius Biotech, Inc., 9/F, Innov Tower, Zone A, no. 1801 Hongmei Road, Xuhui District, Shanghai, China.
Lu Y; Activemotif, Inc., 1914 Palomar Oaks Way, Suite 150, Carlsbad, CA 92008, USA.; AbCipher Biotechnology, 188 Xinjun Ring Road, Building 2, 4th Floor, Minhang District, Shanghai 201114, China.
MacCamy A; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
McGuire AT; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
Palser AL; Kymab, Ltd., The Bennet Building, Babraham Research Campus, Cambridge CB22 3AT, UK.
Rabbitts TH; Quadrucept Bio, Ltd., Cambridge CB23 6DW, UK.; Institute of Cancer Research, Centre for Cancer Drug Discovery, London SM2 5NG, UK.
Rikhtegaran Tehrani Z; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, MD 21201, USA.
Sajadi MM; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, MD 21201, USA.
Sanders RW; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, Netherlands.
Sato AK; Twist Bioscience, 681 Gateway Blvd., South San Francisco, CA 94080, USA.
Schweizer L; HiFiBiO, Inc., 237 Putnam Avenue, Cambridge, MA 02139, USA.
Seo J; Celltrion, Inc., Department of Research and Development, 23 Academy-ro Yeonsu-gu Incheon, Republic of Korea.
Shen B; HiFiBiO, Inc., 237 Putnam Avenue, Cambridge, MA 02139, USA.
Snitselaar JL; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, Netherlands.
Stamatatos L; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
Tan Y; Sanyou Biopharmaceuticals Co., Ltd., no. 188 Xinjunhuan Road, Building 6B-C, 3rd Floor, Minhang District, Shanghai 201114, China.
Tomic MT; National Resilience, Inc., 2061 Challenger Dr., Alameda, CA 94501, USA.
van Gils MJ; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, Netherlands.
Youssef S; Centivax, Inc., 201 Gateway Blvd., Floor 1, South San Francisco, CA 94080, USA.
Yu J; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, 701 West 168th St., HHSC 1102, New York, NY 10032, USA.
Yuan TZ; Twist Bioscience, 681 Gateway Blvd., South San Francisco, CA 94080, USA.
Zhang Q; HiFiBiO, Inc., 237 Putnam Avenue, Cambridge, MA 02139, USA.
Peters B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.; Department of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
Tomaras GD; Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.
Germann T; Carterra, 825 N. 300 W. Ste C309, Salt Lake City, UT 84103, USA.
Saphire EO; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.; Department of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.; Pokaż więcej
Corporate Authors:: CoVIC-DB team1
Źródło:: Science (New York, N.Y.) [Science] 2021 Oct 22; Vol. 374 (6566), pp. 472-478. Date of Electronic Publication: 2021 Sep 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Epitope Mapping*
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Immunodominant Epitopes/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Antibodies, Neutralizing/therapeutic use ; Antibodies, Viral/therapeutic use ; Antigens, Viral/chemistry ; Antigens, Viral/immunology ; COVID-19/therapy ; Humans ; Immunodominant Epitopes/chemistry ; Protein Binding ; Protein Domains ; Spike Glycoprotein, Coronavirus/chemistry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays.
Autorzy:: Rikhtegaran Tehrani Z; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, Maryland, United States of America.; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Saadat S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, Maryland, United States of America.; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Saleh E; Division of Epidemiology & Prevention, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Ouyang X; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, Maryland, United States of America.
Constantine N; Division of Epidemiology & Prevention, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
DeVico AL; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Harris AD; Department of Epidemiology and Public Health, University of Maryland School of Medicine Baltimore, Maryland, United States of America.
Lewis GK; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Kottilil S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, Maryland, United States of America.
Sajadi MM; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, Maryland, United States of America.; Division of Vaccine Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Department of Medicine, Baltimore VA Medical Center, Baltimore, Maryland, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Nov 02; Vol. 15 (11), pp. e0237828. Date of Electronic Publication: 2020 Nov 02 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Antibodies, Viral/*blood
Betacoronavirus/*metabolism
Coronavirus Infections/*diagnosis
Immunoassay/*methods
Nucleocapsid/*immunology
Pneumonia, Viral/*diagnosis
Spike Glycoprotein, Coronavirus/*immunology
Adult ; Aged ; Aged, 80 and over ; Area Under Curve ; Betacoronavirus/isolation & purification ; COVID-19 ; Coronavirus Infections/virology ; Female ; Humans ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/virology ; ROC Curve ; Reproducibility of Results ; SARS-CoV-2

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Rate of re-positive RT-PCR test among patients recovered from COVID-19.
Autorzy:: Habibzadeh P; Persian BayanGene Research and Training Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sajadi MM; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, United States of America.
Emami A; Burn and Wound Healing Research Center, Microbiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Karimi MH; Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Yadollahie M; R&D Headquarters, Petroleum Industry Health Organization, Shiraz, Iran.
Kucheki M; R&D Headquarters, Petroleum Industry Health Organization, Shiraz, Iran.
Akbarpoor S; Department of Nursing, Larestan University of Medical Sciences, Larestan, Iran.
Habibzadeh F; R&D Headquarters, Petroleum Industry Health Organization, Shiraz, Iran.; Pokaż więcej
Źródło:: Biochemia medica [Biochem Med (Zagreb)] 2020 Oct 15; Vol. 30 (3), pp. 030401. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji:: Letter
MeSH Terms:: Clinical Laboratory Techniques*
Reverse Transcriptase Polymerase Chain Reaction*
Betacoronavirus/*genetics
Coronavirus Infections/*diagnosis
Pneumonia, Viral/*diagnosis
COVID-19 ; COVID-19 Testing ; Humans ; Pandemics ; Recovery of Function ; SARS-CoV-2

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Urine Vancomycin Level as a Method for Drug Monitoring in Patients With Normal and Decreased Kidney Function.
Autorzy:: Shokouhi S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Alavi Darazam I
Ayoubian Z
Sajadi MM; Pokaż więcej
Źródło:: Iranian journal of kidney diseases [Iran J Kidney Dis] 2017 Oct; Vol. 11 (5), pp. 367-370.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Bacterial Agents/*urine
Renal Insufficiency/*blood
Renal Insufficiency/*urine
Vancomycin/*urine
Adult ; Drug Monitoring/methods ; Female ; Glomerular Filtration Rate ; Humans ; Kidney/physiopathology ; Male ; Middle Aged ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Comparison of serum PCR assay and histopathology for the diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients with sinus involvement.
Autorzy:: Shokouhi S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mirzaei J; Infectious Disease Research Center, AJA University of Medical Sciences, Tehran, Iran.
Sajadi MM; Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, USA.
Javadi A; Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Pokaż więcej
Źródło:: Current medical mycology [Curr Med Mycol] 2016 Dec; Vol. 2 (4), pp. 46-48.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: IL28B genotype does not correlate with HIV control in African Americans.
Autorzy:: Sajadi MM; Institute of Human Virology at the University of Maryland School of Medicine, Baltimore, Maryland, USA. />Shakeri N
Talwani R
Howell CD
Pakyz R
Redfield RR
Parsa A; Pokaż więcej
Źródło:: Clinical and translational science [Clin Transl Sci] 2011 Aug; Vol. 4 (4), pp. 282-4.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Genetic Predisposition to Disease*
Black or African American/*genetics
HIV Infections/*genetics
HIV Infections/*prevention & control
Interleukins/*genetics
Adult ; Aged ; Alleles ; Cohort Studies ; Demography ; Female ; Humans ; Interferons ; Male ; Middle Aged ; Polymorphism, Single Nucleotide/genetics ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Sajadi MM"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język